Coya Therapeutics, Inc. Provides Business Update and Reports FY 2022 Unaudited Financial Results
Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance function of Regulatory T Cells (Tregs) function, today announced its financial results for …